Literature DB >> 22296279

Synthesis, basicity, structural characterization, and biochemical properties of two [(3-hydroxy-4-pyron-2-yl)methyl]amine derivatives showing antineoplastic features.

Stefano Amatori1, Gianluca Ambrosi, Mirco Fanelli, Mauro Formica, Vieri Fusi, Luca Giorgi, Eleonora Macedi, Mauro Micheloni, Paola Paoli, Roberto Pontellini, Patrizia Rossi.   

Abstract

The N,N'-bis[(3-hydroxy-4-pyron-2-yl)methyl]-N,N'-dimethylethylendiamine (malten) and 4,10-bis[(3-hydroxy-4-pyron-2-yl)methyl]-1,7-dimethyl-1,4,7,10-tetraazacyclododecane (maltonis) were synthesized and characterized. The acid-base behavior, structural characterizations, and biochemical studies in aqueous solution were reported. Each compound contains two 3-hydroxy-2-methyl-4-pyrone units (maltol) symmetrically spaced by a polyamine fragment, the 1,4-dimethylethylendiamine (malten), or the 1,7-dimethyl-1,4,7,10-tetraazacyclododecane (maltonis). They are present at physiological pH 7.4 in the form of differently charged species: neutral but in a zwitterion form for malten and monopositive with an internal separation of charges for maltonis. Malten and maltonis are both able to alter the chromatin structure inducing the covalent binding of genomic DNA with proteins, a feature consistent with the known antiproliferative activity exerted by this class of molecules. Solid-state results and MD simulations in water show that malten, because of its molecular topology, should be more prone than maltonis to act as a donor of H-bonds in intermolecular contacts, thus it should give a better noncovalent approach with the negatively charged DNA. Crystal structures of [H(2)malten](2+) and [H(2)maltonis](2+) cations were also reported.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22296279     DOI: 10.1021/jo202270j

Source DB:  PubMed          Journal:  J Org Chem        ISSN: 0022-3263            Impact factor:   4.354


  4 in total

1.  Crystal structure of bis-{μ2-2,2'-[(4,10-dimethyl-1,4,7,10-tetra-aza-cyclo-dodecane-1,7-di-yl)bis(meth-yl-ene)]bis-(4-oxo-4H-pyran-3-olato)}dicobalt-calcium bis-(perchlorate) 1.36-hydrate.

Authors:  Patrizia Rossi; Eleonora Macedi; Paola Paoli; Luca Giorgi; Mauro Formica; Vieri Fusi
Journal:  Acta Crystallogr E Crystallogr Commun       Date:  2017-11-28

2.  Crystal structure of the BaII-based CoII-containing one-dimensional coordination polymer poly[[aqua{μ4-2,2'-[(4,10-dimethyl-1,4,7,10-tetra-aza-cyclo-dodecane-1,7-di-yl)bis(methylidene)]bis-(4-oxo-4H-pyran-3-olato)}-perchloratocobaltbarium] perchlorate].

Authors:  Paola Paoli; Eleonora Macedi; Patrizia Rossi; Luca Giorgi; Mauro Formica; Vieri Fusi
Journal:  Acta Crystallogr E Crystallogr Commun       Date:  2017-11-03

3.  N,N'-bis-[(3-hy-droxy-4(4H)-oxypyran-2-yl)meth-yl]-N,N'-dimethyl-ethylene-1,2-diammonium tetra-chloridoplatinate(II) dihydrate.

Authors:  Vieri Fusi; Luca Giorgi; Eleonora Macedi; Paola Paoli; Patrizia Rossi
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2012-10-06

4.  An aza-macrocycle containing maltolic side-arms (maltonis) as potential drug against human pediatric sarcomas.

Authors:  Clara Guerzoni; Stefano Amatori; Luca Giorgi; Maria Cristina Manara; Lorena Landuzzi; Pier-Luigi Lollini; Aurora Tassoni; Mauro Balducci; Marco Manfrini; Loredana Pratelli; Massimo Serra; Piero Picci; Mauro Magnani; Vieri Fusi; Mirco Fanelli; Katia Scotlandi
Journal:  BMC Cancer       Date:  2014-02-27       Impact factor: 4.430

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.